Professional Documents
Culture Documents
To cite this article: B. Schick & G. Kahle (2000) Radiological Findings in Angiofibroma, Acta
Radiologica, 41:6, 585-593, DOI: 10.1080/028418500127345956
Review Article
Abstract
Surgery after pre-operative embolization has become the main treatment mo- Key words: Head and neck,
dality in angiofibroma therapy. As surgical planning is based on precise pre- angiofibroma; CT; MR imaging;
operative tumour evaluation, knowledge of the characteristic growth patterns paediatric.
is of great interest. Analysis of tumour extension and blood supply, as well as
methods of controlling intra-operative bleeding, help in determining the appro- Correspondence: Bernhard Schick,
priate surgical approach. Though benign, angiofibroma demonstrates a locally Department of Ear-, Nose- and
aggressive nature. This fibrovascular tumour is characterised by typical radio- Throat Diseases, University Hospital
logical findings and by predictable growth patterns. The tumour extension and Fulda, University of Marburg,
blood supply can be accurately determined by CT, MR imaging and angiogra- Pacelliallee 4, D-36043 Fulda,
phy. With classic radiological findings, no pre-operative biopsy is necessary in Germany. FAX π49 661 84 6002.
most angiofibromas. Advances in radiological imaging have contributed to im-
proved surgical planning and tumour resection. The surgeon is able to select Accepted for publication 26 April
the least traumatic approach with secure haemostatic control, which is also 2000.
critical for avoiding the disturbance of facial skeletal growth in this group of
young patients. Embolization, pre-operative autologous donation and the cell
saver system for immediate retransfusion of the collected blood after filtration,
are important tools for dealing with blood loss in angiofibroma surgery as they
minimize homologous blood transfusion.
Angiofibromas represent less than 0.5% of all head endothelial-lined vascular spaces with little or no
and neck tumours (8). They occur almost exclus- smooth muscle layers, angiofibromas tend to bleed
ively in adolescent males and were therefore pre- profusely. Therefore, methods to reduce intra-op-
viously termed juvenile angiofibroma. The age of erative blood loss (pre-operative embolization, cell
diagnosis most commonly ranges between 14 and saver) have attracted much attention as they mini-
25 years (10) and manifestation in other age mize the need for transfusion during surgery.
groups or females is rare. The tissue of origin is In this article we present the specific radiological
still unclear. Angiofibromas usually arise in the re- findings in angiofibromas based on experience in
gion of the posterior nares in close relationship to dealing with this rare tumour over an 18-year
the sphenopalatine foramen (4). Although benign, period.
they show aggressive growth behaviour and spread
through natural foraminas and fissures (8).
Tumour imaging
Surgery is the main treatment modality (20). Ex-
act determination of the site of origin, extension From June 1, 1980 until December 31, 1998, 36
and blood supply of this fibrovascular tumour is angiofibromas were treated at the University Hos-
required prior to surgery. Due to the characteristic pital Fulda. Thirty-six CT and 22 MR examina-
585
B. SCHICK AND G. KAHLE
586
RADIOLOGICAL FINDINGS IN ANGIOFIBROMA
587
B. SCHICK AND G. KAHLE
Classification of angiofibromas
Different classification systems relying on the
radiological findings have been proposed for
588
RADIOLOGICAL FINDINGS IN ANGIOFIBROMA
589
590
Table 1
Synopsis of classification systems for angiofibromas
Johns et al., 1980 Chandler et al., 1984 Fisch, 1983 Andrews et al., 1989 Sessions et al., 1981 Radkowski et al., 1996
I. Disease confined to the I. Tumour confined to I. Tumour limited to the I. Tumour limited to the IA. Tumour limited to IA. Limited to nose and/or
nasopharynx and nasal cavity nasopharynx nasopharynx and nasocavity nasopharynx and nasal cavity. posterior nares and/or nasopharyngeal vault
with no bone destruction Bone destruction negligible or nasopharyngeal vault. No
limited to the sphenopalatine paranasal sinus extension
foramen
II. Disease involving nasopharynx II. Tumour extending into II. Tumour invading the II. Tumour invading the IB. Same as IA but with IB. Extension into
or nasal cavity with extension to nasal cavity and/or sphenoid pterygomaxillary fossa, the pterygomaxillary fossa or the extension into one or more Øone sinus
the pterygomaxillary fossa and/or sinus maxillary, ethmoid and maxillary, ethmoid, or paranasal sinuses
maxillary sinus sphenoid sinuses with bone sphenoid sinus with bone
destruction destruction
III. Involvement of more than the III. Tumour extending into one III. Tumour invading the IIIa. Tumour invading the IIA. Minimal lateral extension IIA. Minimal extension into
anatomic sites listed in II, but or more of the following: infratemporal fossa, orbit and infratemporal fossa or orbital through the sphenopalatine pterygomaxillary fossa
without intracranial involvement antrum, ethmoid sinus, parasellar region remaining region without intracranial foramen, into and including a
pterygomaxillary fossa, lateral to the cavernous sinus involvement minimal part of the medial-
infratemporal fossa, orbit, and/ most part of the
or cheek pterygomaxillary fossa
IV. Intracranial extension IV. Tumour extending into IV. Tumour with massive IIIb. Tumour invading the IIB. Full occupation of the IIB. Full occupation of
cranial cavity invasion of the cavernous infratemporal fossa or orbital pterygomaxillary fossa, pterygomaxillary fossa with or
sinus, the optic chiasmal region region with intracranial displacing the posterior wall of without erosion of orbital bone
or pituitary fossa extradural (parasellar) the maxillary antrum forewards.
involvement Lateral and/or anterior
B. SCHICK AND G. KAHLE
displacement of branches of
the maxillary artery. Superior
extension may occur, eroding
the orbital bones
IVa. Intracranial intradural IIC. Extension through the IIC. Infratemporal fossa with
tumour without infiltration of pterygomaxillary fossa into or without cheek or posterior to
the cavernous sinus, pituitary the cheek and temporal fossa pterygoid plates
fossa, or optic chiasm
IVb. Intracranial intradural III. Intracranial extension IIIA. Erosion of skull base –
tumour with infiltration of the minimal intracranial
cavernous sinus, pituitary
fossa, or optic chiasm
IIIB. Erosion of skull base –
extensive intracranial with or
without cavernous sinus
RADIOLOGICAL FINDINGS IN ANGIOFIBROMA
591
B. SCHICK AND G. KAHLE
Postoperative follow-up
The effectiveness of surgical therapy is analysed by
endoscopic and radiological follow-up. Careful fol-
low-up is of special importance as recurrence has
been reported in up to 25% of the cases (3). MR
imaging is indicated as the first choice modality
for radiological follow-up. It offers the best soft
tissue definition and it also avoids irradiation of
young patients. To document the bony changes
Fig. 17. Angiographic findings before (a) and after (b) super- after surgery, we performed an additional baseline
selective embolization with polyvinyl alcohol particles of an CT examination 3 months after surgery. In those
angiofibroma fed from the maxillary artery. paranasal sinuses involved at surgery, mucosal
swelling was found in the postoperative course
(Fig. 18a). During the wound healing process,
granulation tissue shows contrast enhancement at
MR imaging. Differentiation between granulation
tissue and residual tumour may be difficult at the
first control examination. During further follow-
up, the question of residual tumour or reparative
changes is answered by comparison with earlier in-
vestigations (Fig. 18b). While stable or decreased
enhancement indicate fibrosis, increased enhance-
ment indicates tumour recurrence.
Conclusion
Angiofibroma presents as a rare tumour with a
Fig. 18. (a) Axial MR image of mucosal swelling at the confines predictable growth pattern and typical radiological
of the maxillary sinus three months after endonasal angio-
fibroma resection. (b) Axial MR imaging two years after
findings. The knowledge of the tumour behaviour
surgery indicates no tumour recurrence but a thin mucosal is of major interest to both the radiologist and the
cover of the maxillary sinus. surgeon. With classical radiological findings, a pre-
operative biopsy is usually not necessary nor ad-
visable. Advances in accurate determination of the
tumour extension by high-resolution CT and MR
bolization may also be useful in situations where imaging improve surgical planning and reduce the
the external carotid artery has already been ligated risk of recurrence. In combination with angiogra-
during previous surgical treatment. phic evaluation of the tumour blood supply, the
least traumatic approach for complete resection
Cell saver and autologous blood banking
can be choosen. The aim of reducing intra-operat-
ive blood loss is achieved by pre-operative em-
To achieve tumour resection without need for bolization, the cell saver system and PAOD.
homologous blood transfusion, the intra-operative
use of the cell saver system (4) and pre-operative ACKNOWLEDGEMENT
autologous blood donation (POAD) are important
supportive measures (5). After blood filtration, the We dedicate this article to Professor Dr. W. Draf on the oc-
cell saver system allows for immediate transfusion casion of his 60th birthday.
of blood lossed intra-operatively. We have used the
cell saver since 1989 in surgical treatment of 20 REFERENCES
angiofibromas with an average autotranfusion vol- 1. A J. C., F U., V A., A U. &
ume of 3000 ml of collected blood. POAD should M M. S.: The surgical management of extensive naso-
be offered to every patient. Since 1995, 10 patients pharyngeal angiofibromas with the infratemporal fossa ap-
opted for POAD. We were able to avoid homo- proach. Laryngoscope 99 (1989), 429.
2. C J. R., G R., M L. & Q-
logous blood transfusion in 20 out of 35 surgically R. M.: Nasopharyngeal angiofibromas. Staging and
treated angiofibromas by use of embolization, cell management. Ann. Otol. Rhinol. Laryngol. 93 (1984),
saver and autologous blood banking. 322.
592
RADIOLOGICAL FINDINGS IN ANGIOFIBROMA
3. D J. E. & D A. J.: Spontaneous regression of fibromas of the nasopharynx – 34 cases. Rhinology 27
juvenile nasopharyngeal angiofibroma. Ann. Otol. Rhinol. (1989), 149.
Laryngol. 101 (1992), 469. 14. R D., MG T., H G. B., O L. &
4. D W.: Juvenile angiofibroma. In: Surgery of cranial J D. T.: Angiofibroma. Changes in staging and treat-
base tumors. Edited by L. N. Sekhar and I. P. Janecka. ment. Arch. Otolaryngol. Head Neck Surg. 122 (1996),
Raven Press, New York 1993. 122.
5. F J. J., S C. H., C R. L. & J 15. S B., K G., H R. & D W.: Chemother-
I. P.: Nasopharyngeal angiofibromas. Selecting a surgical apie des juvenilen Angiofibroms – eine Alternative? HNO
approach. Head Neck 19 (1997), 391. 44 (1996), 148.
6. F U.: The infratemporal fossa approach for naso- 16. S B., K M., S G., W R. & D
pharyngeal tumors. Laryngoscope 93 (1983), 36. W.: Das frühkindliche Angiofibrom in ungewöhnlicher Lo-
7. G-C E., B S., R D. et al.: Pre- kalisation. HNO 45 (1997), 1022.
operative embolization of naso-pharyngeal angiofibromas. 17. S R. B., B R. N., N R. M. & A
Neuroradiology 30 (1988), 556. B. R.: Radiographic staging of juvenile angiofibroma.
8. G P.J., D J., O’D T. & F V.: Juv- Head Neck Surg. 3 (1981), 279.
enile angiofibroma. A review of the literature and a case 18. S T. M. J., L J. P., T T. A.,
series report. Laryngoscope 102 (1992), 928. L A. S. S. & J K. E.: Value of pre-operative
9. J M. E., ML R. & C R. W.: Estrogen embolization in surgery for nasopharyngeal angiofibroma.
receptors in nasopharyngeal angiofibromas. Laryngoscope J. Laryngol. Otol. 107 (1993), 514.
90 (1980), 628. 19. T P., B M., H P., W M. & C-
10. K C. J. & B S. R.: Extended transnasal ap- A.: Direct intratumoral embolization of juvenile angio-
proach to pterygomaxillary tumors. Ann. Otolaryngol. 91 fibroma. Am. J. Otolaryngol. 15 (1994), 429.
(1982), 391. 20. U K., B R. M., W R. S., C
11. L P.: Nasopharyngeal angiofibromas. Hazards of D. L., W P. F. & G H.: Juvenile nasopharyngeal
embolization. Radiology 136 (1980), 119. angiofibroma. An update of therapeutic management.
12. M G., C C., G R. et al.: Juvenile naso- Head Neck 18 (1996), 60.
pharyngeal angiofibroma. Comparison of blood loss dur- 21. V A.: Interventional neuroradiology of skull base
ing removal in embolized group versus nonembolized tumors. In: Microsurgery of the skull base. Edited by U.
group. Cardiovasc. Intervent. Radiol. 18 (1995), 158. Fisch and D. Mattox. Georg Thieme Verlag, Stuttgart
13. P J. J. & C D.: Surgical experience of angio- 1988.
593